title: Differential cellular expression of neurotrophins in cortical tubers of the tuberous sclerosis complex.
abstract: Neurotrophins and their receptors modulate cerebral cortical development. Tubers in the tuberous sclerosis complex (TSC) are characterized histologically by disorganized cortical cytoarchitecture and thus, we hypothesized that expression of neurotrophin mRNAs and proteins might be altered in tubers. Using in situ transcription and mRNA amplification to probe cDNA arrays, we found that neurotrophin-3 (NT3) and trkB mRNA expression were reduced whereas neurotrophin-4 (NT4) and trkC mRNA expression were increased in whole tuber sections. Alterations in mRNA abundance were defined in single microdissected dysplastic neurons (DNs) and giant cells (GCs). NT3 mRNA expression was reduced in GCs and trkB mRNA expression was reduced in DNs. NT4 mRNA expression was increased in DNs and trkC mRNA expression was increased in both DNs and GCs. In three patients, TSC2 locus mutations were confirmed and the mean tuberin mRNA expression levels was reduced across all nine cases. Consistent with these observations, NT3 mRNA expression was reduced but trkC mRNA expression was increased in vitro in human NTera2 neurons (NT2N) transfected with a tuberin antisense construct that reduced tuberin expression. Western analysis of tuber homogenates and computer-assisted densitometry of immunolabeled sections confirmed the neurotrophin mRNA expression data in whole sections and single neurotrophin immunoreactive cells. We conclude that alterations in NT4/trkB and NT3/trkC expression may contribute to tuber formation during brain development as downstream effects of the hamartin and tuberin pathway in TSC.
authors.affiliation: Department of Neurology, Penn Epilepsy Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.
authors.forename: R
authors.initials: R
authors.lastname: Kyin
authors.forename: Y
authors.initials: Y
authors.lastname: Hua
authors.forename: M
authors.initials: M
authors.lastname: Baybis
authors.forename: B
authors.initials: B
authors.lastname: Scheithauer
authors.forename: D
authors.initials: D
authors.lastname: Kolson
authors.forename: E
authors.initials: E
authors.lastname: Uhlmann
authors.forename: D
authors.initials: D
authors.lastname: Gutmann
authors.forename: P B
authors.initials: PB
authors.lastname: Crino
mesh_terms: D000293:Adolescent; D000328:Adult; D016375:Antisense Elements (Genetics) / Q000235:genetics; D015153:Blotting, Western; D002460:Cell Line; D002540:Cerebral Cortex / Q000378:metabolism* / Q000473:pathology*; D002648:Child; D002675:Child, Preschool; D005260:Female; D005784:Gene Amplification; D015870:Gene Expression; D005838:Genotype; D015726:Giant Cells / Q000502:physiology; D006801:Humans; D007150:Immunohistochemistry; D007223:Infant; D008297:Male; D008875:Middle Aged; D009414:Nerve Growth Factors / Q000235:genetics / Q000378:metabolism*; D009474:Neurons / Q000473:pathology / Q000502:physiology; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D012097:Repressor Proteins / Q000235:genetics / Q000378:metabolism; D014162:Transfection; D014402:Tuberous Sclerosis / Q000235:genetics / Q000378:metabolism* / Q000473:pathology*; D000077005:Tuberous Sclerosis Complex 2 Protein; D025521:Tumor Suppressor Proteins
chemical_list: D016375:Antisense Elements (Genetics); D009414:Nerve Growth Factors; D012333:RNA, Messenger; D012097:Repressor Proteins; C000624653:TSC2 protein, human; D000077005:Tuberous Sclerosis Complex 2 Protein; D025521:Tumor Suppressor Proteins